CytoDyn Inc. Files Definitive Proxy Statement

TL;DR

CytoDyn proxy statement filed, shareholders vote Nov 22.

AI Summary

CytoDyn Inc. filed its definitive proxy statement on October 11, 2024, for its annual meeting on November 22, 2024. The company, previously known as Rexray Corp, is incorporated in Delaware and operates in the pharmaceutical preparations sector. The filing details information related to the solicitation of proxies for the upcoming shareholder meeting.

Why It Matters

This filing provides shareholders with crucial information to make informed decisions regarding company matters and voting at the upcoming annual meeting.

Risk Assessment

Risk Level: low — This is a routine proxy filing providing information to shareholders, not indicating immediate financial risk.

Key Players & Entities

• CytoDyn Inc. (company) — Registrant
• Rexray Corp (company) — Former company name
• 20241122 (date) — Annual meeting date
• 20241011 (date) — Filing date

FAQ

Key Financial Figures

• $0.001 — only shares of common stock, par value $0.001 per share, of the Company are entitled
• $3.36 — common stock with an exercise price of $3.36 per share that will expire on August 31
• $0.50 — common stock with an exercise price of $0.50 per share that will expire on September

Filing Documents

• tmb-20241122xdef14a.htm (DEF 14A) — 655KB
• tmb-20241122xdef14a_a005.jpg (GRAPHIC) — 5KB
• tmb-20241122xdef14a_bg001.jpg (GRAPHIC) — 131KB
• tmb-20241122xdef14a_bg002.jpg (GRAPHIC) — 155KB
• tmb-20241122xdef14a_cg001.jpg (GRAPHIC) — 165KB
• tmb-20241122xdef14a_cg002.jpg (GRAPHIC) — 143KB
• 0001558370-24-013250.txt ( ) — 1484KB

From the Filing

DEF 14A 1 tmb-20241122xdef14a.htm DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material Pursuant to 240.14a-12 CytoDyn Inc. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check the appropriate box): No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11. CYTODYN INC. 1111 Main Street, Suite 660 Vancouver, Washington 98660 (360) 980-8524 October 11, 2024 Dear CytoDyn Stockholder: You are cordially invited to virtually attend the 2024 Annual Meeting of Stockholders of CytoDyn Inc. (the "Company") to be held solely online via a live webcast at 9:30 am, Pacific Time, on November 22, 2024, at https://meetnow.global/MZM9KKF. There is no physical location for the Annual Meeting. To attend and vote at the Annual Meeting, you must be a stockholder of record as of the close of business on September 30, 2024, or hold a legal proxy, as explained in the "Voting, Revocation, and Solicitation of Proxies" and "Attendance at the Annual Meeting" sections of the accompanying proxy statement. The matters to be presented for action at the Annual Meeting are (i) the election of five directors to our Board of Directors; (ii) ratification, on an advisory (non-binding) basis, of the appointment of our auditors, Marcum LLP; and (iii) approval, on an advisory (non-binding) basis, of our named executive officer compensation. We may also act on such other business as may properly come before the Annual Meeting. We are excited about the future of our company. It is vitally important that your shares are represented and voted, whether or not you are able to attend the virtual meeting. We urge you to promptly vote and submit your proxy (1) via the Internet, (2) by phone, or (3) if you received your proxy materials by mail, by signing, dating, and returning the enclosed proxy card or voting instruction form in the envelope provided for your convenience. Sincerely, Dr. Jacob Lalezari Chief Executive Officer If you have any questions or require any assistance in voting your shares, please contact our transfer agent: Computershare 1-866-641-4276 CytoDyn Inc. Legal Proxy P.O. Box 43001 Providence, RI 029403001 CYTODYN INC. NOTICE OF ANNUAL MEETING OF STOCKHOLDERS November 22, 2024 You are invited to virtually attend the 2024 Annual Meeting of Stockholders (the "Annual Meeting") of CytoDyn Inc., a Delaware corporation (the "Company"), to be held at 9:30 am, Pacific Time, on November 22, 2024, via a live webcast at https://meetnow.global/MZM9KKF. The Board of Directors has fixed September 30, 2024, as the record date for the meeting. Only stockholders of record at the close of business on September 30, 2024, or who hold a legal proxy, are entitled to notice of, to vote at, and to virtually attend the Annual Meeting or any postponements or adjournments thereof. Please refer to the "Voting, Revocation, and Solicitation of Proxies" and "Attendance at the Annual Meeting" sections of the accompanying Proxy Statement for additional information. The Annual Meeting is being held to consider and vote on the following matters: 1. Election of five (5) directors to serve on the Board of Directors until the 2025 Annual Meeting of Stockholders, until their successors are duly elected and qualified or until their earlier death, resignation or removal; 2. Ratification, on an advisory (non-binding) basis, of the selection of Marcum LLP as our independent registered public accounting firm for the fiscal year ending May 31, 2025; 3. Approval, on an advisory (non-binding) basis, of our named executive officer compensation; and 4. Transaction of any other business as may properly come before the Annual Meeting or any postponements or adjournments thereof. Whether or not you are able to virtually attend the meeting, please promptly vote and submit your proxy (1) via the internet, (2) by phone, or (3) if you received your proxy materials by mail, by signing, dating, and returning the enclosed proxy card or voting instruction form in the envelope provided for your convenience. If you are a stockholder of record at the close of business on September 30, 2024, or hold a legal proxy, and virtually attend the Annual Meeting, you may revoke your proxy and vote your shares at the meeting. The Board of Directors of the Company recommends that you vote "FOR" the election of the Board's nominees for directors named i

View Full Filing

View this DEF 14A filing on SEC EDGAR